about
Development and feasibility of a home-based education model for families of children with sickle cell diseaseSocial skills and executive function among youth with sickle cell disease: a preliminary investigationControlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.Need for cognitive rehabilitation for children with sickle cell disease and strokes.Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Parent education and biologic factors influence on cognition in sickle cell anemiaThe Association of Cytokine Levels With Cognitive Function in Children With Sickle Cell Disease and Normal MRI Studies of the BrainAssociated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Youth with Sickle Cell Disease: Genetic and Sexual Health Education Needs.Association of social-environmental factors with cognitive function in children with sickle cell diseaseThe National Children's Study: Recruitment Outcomes Using an Enhanced Household-Based Approach.Community Health Workers as Support for Sickle Cell CareCerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell diseaseClinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience.Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia.Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease.Sickle cell disease and implementation science: A partnership to accelerate advances.The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology.Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.Design of the silent cerebral infarct transfusion (SIT) trial.Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab.Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.Radiation therapy for pilocytic astrocytomas of childhood.Children with sickle cell disease: the case for developmental screening.Executive function performance on the children's kitchen task assessment with children with sickle cell disease and matched controls.A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes.Mentoring Program for Young Adults with Sickle Cell Disease.Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia.Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthoodAdolescent survivors' information needs for transitions to postsecondary education and employmentIdentification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastomaLow frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndromeBlood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarctsA multidisciplinary health care team's efforts to improve educational attainment in children with sickle-cell anemia and cerebral infarctsMoving from gene discovery to clinical trials in Hutchinson-Gilford progeria syndrome
P50
Q31150442-98477BD7-806E-480C-8AD0-32BC2E4A140FQ33636794-97AE3A49-B0A4-48A3-9A99-0B4B5EB90C0CQ34330904-22809CBF-A9B4-417F-A2AF-AC8966D57B41Q34665167-DAA5F938-79B3-443C-9ED6-BE23FB3E4391Q34749681-30412AFC-C644-4E8C-850C-A0DCB8C1B9BAQ35007607-BF01C04D-720C-4A9B-ACBA-1D0E8BB89D1DQ35026922-1798964F-4096-4630-B1B2-0D826A30BF92Q35739099-C1C905B6-72C1-41E5-A7B0-F56E599AA9B9Q35909642-9D917D09-F599-4CD7-9004-D7ECC8E8E2DDQ36543928-C50E62C6-4094-4C25-8436-5B337A825F2FQ36902140-613EADB9-2BA4-475F-A90A-D3AC1DBEBF0BQ36930000-96E038BB-7CA8-4F14-A647-CC00E9164EDEQ37032152-8A2B631D-FE78-46BA-A6EC-A4EE92A9F508Q37459664-08543455-B455-497C-B45C-A40E054E0AB1Q37691154-92A62514-DF2F-4CF1-A7A9-799225782CECQ37894016-98EAB0E7-8EC6-4EEE-99D6-F97A3A56A7CFQ38186701-882A71BB-06DD-49DC-B614-E18C2483761FQ38942105-7B3650D0-F90E-4B7E-B970-50796417D3F1Q39337770-522B344E-0DE4-45ED-8D69-5A71EC5E5E9CQ40512765-BABA7B00-D75C-4FA7-B834-55CACCEFA0B3Q41010661-BE51DEDB-95D5-4BA3-AC90-3F32692786DFQ41527748-96AED315-A165-4629-8E4B-F1A6DF373CF4Q46901089-B0F3B59A-FD19-4103-B5C0-F79042EC489AQ48025914-B95F657B-8EDF-4080-B31E-5E8E04B8CD05Q48079152-07A0C2EA-1EA8-43D1-84DF-4FE3FD82DFB6Q48223568-96FC7E97-2C9E-4447-A2C0-CDE29F2F2A8CQ50420396-56A62778-9A7F-4D57-83FE-04F49C080034Q51004065-D317384F-42DC-4C48-B636-CFB4E18E63E5Q51974723-F6D2086C-DD55-4124-B8FB-2F2A1BD14B04Q52357513-499F351F-A67C-4A28-98C4-00EB3104465CQ52589715-F524A48E-5D77-40DB-BAC2-57A904DBC870Q52739085-4B0E9C9D-5F66-4F23-9AE9-0A586A1960C0Q55435851-A27DF362-76A6-4A00-94BB-BAF2BE8006A6Q57165813-1A60363F-5FD5-49DF-8084-669638DE0364Q58587507-5757112A-7297-42B0-8B32-093D25EDB0D3Q79353558-FB41ADE0-5A26-4C5D-9D77-186833988068Q79852892-5196463A-AAA0-46B5-BD99-E15C9B1F6C4EQ81557783-9978F8FE-9FCD-4E93-BD43-25EA01F77BEFQ82466583-3F2E1DEA-BBD4-4B57-A62D-DA7DA5C881D7Q87166833-27B18CB6-FA78-4F1C-B2D8-FC7BD046EF51
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Allison A King
@ast
Allison A King
@en
Allison A King
@es
Allison A King
@nl
type
label
Allison A King
@ast
Allison A King
@en
Allison A King
@es
Allison A King
@nl
prefLabel
Allison A King
@ast
Allison A King
@en
Allison A King
@es
Allison A King
@nl
P106
P1153
7403373161
P31
P496
0000-0002-1951-6176